GlassScriptPhysician profile
Veronika Sadykov
NPI 1902480494
$764.09
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $608 · 2023: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.60 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.60 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $335.02 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $67.39 | 2022 | |
| Abbvie INC. | $65.10 | 2022 | |
| Janssen Biotech, INC. | $64.95 | 2023 | Tremfya |
| Amgen INC. | $60.61 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $59.09 | 2022-2023 | Sotyktu |
| Incyte Corporation | $48.97 | 2022 | |
| Sun Pharmaceutical Industries INC. | $31.67 | 2022 | |
| Pfizer INC. | $16.84 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronika Sadykov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.